newsfilter
← Latest News
GlobeNewswire·

AzurRx BioPharma Announces $3.0 Million Bought Deal Offering of Common Stock

BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), ("AzurRx" or the "Company"), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal